Diagnosis, treatment, and new developments in preeclampsia

Katherine W. Arendt, William Hartman, Vesna D Garovic

Research output: Contribution to journalArticle

Abstract

Preeclampsia remains a leading cause of maternal and fetal morbidity and mortality in the United States and worldwide. Despite its significant prevalence (5% of all otherwise normal pregnancies may be affected), there is no early pregnancy screening test to recognize those at risk. Further, once diagnosed, there is no effective treatment beyond delivery. Emerging data are beginning to uncover the pathogenesis of this complex disease. In this review, the clinical presentation, current management, new evidence regarding pathogenesis, and future possibilities for screening and therapy will be discussed.

Original languageEnglish (US)
Pages (from-to)297-302
Number of pages6
JournalCurrent Women's Health Reviews
Volume6
Issue number4
DOIs
StatePublished - Nov 2010

Fingerprint

Pregnancy Tests
Fetal Mortality
Pre-Eclampsia
Mothers
Morbidity
Pregnancy
Therapeutics

Keywords

  • Eclampsia
  • Preeclampsia
  • Pregnancy induced hypertension

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Diagnosis, treatment, and new developments in preeclampsia. / Arendt, Katherine W.; Hartman, William; Garovic, Vesna D.

In: Current Women's Health Reviews, Vol. 6, No. 4, 11.2010, p. 297-302.

Research output: Contribution to journalArticle

Arendt, Katherine W. ; Hartman, William ; Garovic, Vesna D. / Diagnosis, treatment, and new developments in preeclampsia. In: Current Women's Health Reviews. 2010 ; Vol. 6, No. 4. pp. 297-302.
@article{19c4309b2ac246edb5111a1072836f64,
title = "Diagnosis, treatment, and new developments in preeclampsia",
abstract = "Preeclampsia remains a leading cause of maternal and fetal morbidity and mortality in the United States and worldwide. Despite its significant prevalence (5{\%} of all otherwise normal pregnancies may be affected), there is no early pregnancy screening test to recognize those at risk. Further, once diagnosed, there is no effective treatment beyond delivery. Emerging data are beginning to uncover the pathogenesis of this complex disease. In this review, the clinical presentation, current management, new evidence regarding pathogenesis, and future possibilities for screening and therapy will be discussed.",
keywords = "Eclampsia, Preeclampsia, Pregnancy induced hypertension",
author = "Arendt, {Katherine W.} and William Hartman and Garovic, {Vesna D}",
year = "2010",
month = "11",
doi = "10.2174/157340410793362195",
language = "English (US)",
volume = "6",
pages = "297--302",
journal = "Current Women's Health Reviews",
issn = "1573-4048",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Diagnosis, treatment, and new developments in preeclampsia

AU - Arendt, Katherine W.

AU - Hartman, William

AU - Garovic, Vesna D

PY - 2010/11

Y1 - 2010/11

N2 - Preeclampsia remains a leading cause of maternal and fetal morbidity and mortality in the United States and worldwide. Despite its significant prevalence (5% of all otherwise normal pregnancies may be affected), there is no early pregnancy screening test to recognize those at risk. Further, once diagnosed, there is no effective treatment beyond delivery. Emerging data are beginning to uncover the pathogenesis of this complex disease. In this review, the clinical presentation, current management, new evidence regarding pathogenesis, and future possibilities for screening and therapy will be discussed.

AB - Preeclampsia remains a leading cause of maternal and fetal morbidity and mortality in the United States and worldwide. Despite its significant prevalence (5% of all otherwise normal pregnancies may be affected), there is no early pregnancy screening test to recognize those at risk. Further, once diagnosed, there is no effective treatment beyond delivery. Emerging data are beginning to uncover the pathogenesis of this complex disease. In this review, the clinical presentation, current management, new evidence regarding pathogenesis, and future possibilities for screening and therapy will be discussed.

KW - Eclampsia

KW - Preeclampsia

KW - Pregnancy induced hypertension

UR - http://www.scopus.com/inward/record.url?scp=79959358220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959358220&partnerID=8YFLogxK

U2 - 10.2174/157340410793362195

DO - 10.2174/157340410793362195

M3 - Article

AN - SCOPUS:79959358220

VL - 6

SP - 297

EP - 302

JO - Current Women's Health Reviews

JF - Current Women's Health Reviews

SN - 1573-4048

IS - 4

ER -